Indications for therapeutic apheresis in hematological disorders

Klein, 1986, Clinical applications of therapeutic apheresis. Report of the Clinical Applications Committee, American Society for Apheresis, J Clin Apher, 3 McLeod, 1993, Management of hematological disorders and cancer, J Clin Apher, 8, 211, 10.1002/jca.2920080404 Strauss, 1993, An overview of current management, J Clin Apher, 8, 189, 10.1002/jca.2920080402 McLeod, 2000, Introduction to the third special issue: clinical applications of therapeutic apheresis, J Clin Apher, 15, 1, 10.1002/(SICI)1098-1101(2000)15:1/2<1::AID-JCA1>3.0.CO;2-R Padmanabhan, 2019, Guidelines on the Use of Therapeutic Apheresis in Clinical Practice - Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue, J Clin Apher, 34, 171, 10.1002/jca.21705 Connelly-Smith, 2019, The 2019 guidelines from the American Society for Apheresis: what's new?, Curr Opin Hematol, 26, 461, 10.1097/MOH.0000000000000534 Szczepiorkowski, 2007, Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis, J Clin Apher, 22, 106, 10.1002/jca.20129 Szczepiorkowski, 2007, The new approach to assignment of ASFA categories–introduction to the fourth special issue: clinical applications of therapeutic apheresis, J Clin Apher, 22, 96, 10.1002/jca.20134 Szczepiorkowski, 2010, Guidelines on the use of therapeutic apheresis in clinical practice–evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis, J Clin Apher, 25, 83, 10.1002/jca.20240 Schwartz, 2013, Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the american society for apheresis: the sixth special issue, J Clin Apher, 28, 145, 10.1002/jca.21276 Schwartz, 2016, Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue, J Clin Apher, 31, 149 Guyatt, 2008, GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ, 336, 924, 10.1136/bmj.39489.470347.AD Sarode, 2014, Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research, J Clin Apher, 29, 148, 10.1002/jca.21302 Upadhyay, 2019, Utilizing a PLASMIC score-based approach in the management of suspected immune thrombotic thrombocytopenic purpura: a cost minimization analysis within the Harvard TMA Research Collaborative, Br J Haematol, 186, 490, 10.1111/bjh.15932 Scully, 2019, Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura, The New England journal of medicine, 380, 335, 10.1056/NEJMoa1806311 Knoebl, 2020, Efficacy and safety of open-label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study, J Thromb Haemost, 18, 479, 10.1111/jth.14679 Murphree, 2020, When to consider targeted therapies in thrombotic microangiopathies in the modern era: walking the tightrope between cost, safety, and efficacy, J Thromb Thrombolysis, 49, 602, 10.1007/s11239-020-02094-8 2017, Cytapheresis, 75 Freireich, 1960, A distinctive type of intracerebral hemorrhage associated with "blastic crisis" in patients with leukemia, Cancer, 13, 146, 10.1002/1097-0142(196001/02)13:1<146::AID-CNCR2820130126>3.0.CO;2-1 Lightman, 1973, Rheology of leukocytes, leukocyte suspensions, and blood in leukemia. Possible relationship to clinical manifestations, J Clin Invest, 52, 350, 10.1172/JCI107191 Steinberg, 1971, Effect of high concentrations of leukocytes on whole blood viscosity, Blood, 38, 299, 10.1182/blood.V38.3.299.299 Harris, 1978, Leukostasis associated with blood transfusion in acute myeloid leukaemia, Br Med J, 1, 1169, 10.1136/bmj.1.6121.1169 Bandarenko, 2010, Therapeutic Leukocyte and Platelet Depletion, 251 Porcu, 2000, Hyperleukocytic leukemias and leukostasis: a review of pathophysiology, clinical presentation and management, Leuk Lymphoma, 39, 1, 10.3109/10428190009053534 Porcu, 2002, Leukocytoreduction for acute leukemia, Ther Apher, 6, 15, 10.1046/j.1526-0968.2002.00402.x Liesveld, 2006, Acute myelogenous leukemia, 1183 McKee, 1974, Intravascular leukocyte thrombi and aggregates as a cause of morbidity and mortality in leukemia, Medicine (Baltimore), 53, 463, 10.1097/00005792-197411000-00006 Lichtman, 2006, Chronic myelogenous leukemia and related disorders, 1237 Smith, 2004, Case report: mantle cell lymphoma, prolymphocytoid variant, with leukostasis syndrome, Mod Pathol, 17, 879, 10.1038/modpathol.3800139 Dutcher, 1987, Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival, J Clin Oncol, 5, 1364, 10.1200/JCO.1987.5.9.1364 Davidson, 2004, Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome, Am J Med, 116, 546, 10.1016/j.amjmed.2003.09.045 Porcu, 1997, Therapeutic leukapheresis in hyperleucocytic leukaemias: Lack of correlation between degree of cytoreduction and early mortality rate, Br J Haematol, 98, 433, 10.1046/j.1365-2141.1997.1943011.x Giles, 2001, Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival, Leuk Lymphoma, 42, 67, 10.3109/10428190109097677 Thiebaut, 2000, Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis, Ann Hematol, 79, 501, 10.1007/s002770000162 Chang, 2007, Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage, Am J Hematol, 82, 976, 10.1002/ajh.20939 Sarode, 2017, Red blood cell exchange: 2015 American Society for Apheresis consensus conference on the management of patients with sickle cell disease, J Clin Apher, 32, 342, 10.1002/jca.21511 Choi, 2010, Photopheresis, 615 Knobler, 2001, Extracorporeal photochemoimmunotherapy in cutaneous T cell lymphoma, Ann N Y Acad Sci, 941, 123, 10.1111/j.1749-6632.2001.tb03716.x Zic, 2003, The treatment of cutaneous T-cell lymphoma with photopheresis, Dermatol Ther, 16, 337, 10.1111/j.1396-0296.2003.01646.x Hristov, 2019, Mycosis fungoides and Sezary syndrome: 2019 update on diagnosis, risk-stratification, and management, Am J Hematol, 94, 1027, 10.1002/ajh.25577 Ollila, 2019, Mogamulizumab: a new tool for management of cutaneous T-cell lymphoma, Onco Targets Ther, 12, 1085, 10.2147/OTT.S165615 Cutler, 2009, Acute Graft-vs-Host Disease, 331 Pusic, 2009, Chronic Graft-vs-Host Disease, 345 Dall'Amico, 2002, Extracorporeal photochemotherapy for the treatment of graft-versus-host disease, Ther Apher, 6, 296, 10.1046/j.1526-0968.2002.00448.x Foss, 2002, Extracorporeal photopheresis in chronic graft-versus-host disease, Bone Marrow Transplant, 29, 719, 10.1038/sj.bmt.1703529 Knobler, 2009, Extracorporeal photopheresis: past, present, and future, J Am Acad Dermatol, 61, 652, 10.1016/j.jaad.2009.02.039 Couriel, 2006, Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work, Biol Blood Marrow Transplant, 12, 37, 10.1016/j.bbmt.2005.11.009 Couriel, 2006, Extracorporeal photochemotherapy for the treatment of steroid-resistant chronic GVHD, Blood, 107, 3074, 10.1182/blood-2005-09-3907 Foss, 2005, Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors, Bone Marrow Transplant, 35, 1187, 10.1038/sj.bmt.1704984 Greinix, 2006, The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease, Haematologica, 91, 405 Flowers, 2008, A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease, Blood, 112, 2667, 10.1182/blood-2008-03-141481